Recuperative effect of estrogen on rotenone-induced experimental model of Parkinson’s disease in rats
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is described as the loss of dopaminergic neurons located in the substantia nigra (SN) region of the brain and a progressive motor failure. Increased frequency of PD in women, especially after menopause, suggests the effect of estrogen. This view has been supported with empirical studies. Therefore, the effect of estrogen in an experimental model of Parkinson's disease induced by rotenone was investigated. A total of 32 female Wistar Albino rats were randomly assigned to four groups (control group, ovariectomy group, Parkinson's group, Parkinson's + estrogen group). The Parkinson's group received rotenone subcutanously at the dose of 2.5 mg/kg bw, on the 1st, 2nd, 3rd 4th, 6th, 9th, 12th, 15th, 18th, and 21st days animals in the Parkinson's + estrogen group received retonon as in the Parkinson's group and was additionally subcutaneously given estrogen (implant containing 0.5 mg 17 β-estradiol lasting for 21 days). The rats were subjected to rotarod, pole, and swimming tests at the end of the experiment for comparison of their motor activities, and then, histopathological and biochemical analyses were performed on the tissues that were extracted. The rotarod results revealed that Parkinson's group had the shortest time (32.33 ± 3.98 sn) than the groups of control (92.50 ± 12.60 s) ovariectomy (71.42 ± 10.58 s), and Parkinson's + estrogen (71.37 ± 9.26 s). The results of pole disclosed that return and landing time prolonged for Parkinson's group when compared with other groups (return time for control 2.98 ± 0.38 s, ovariectomy 3.02 ± 0.75 s, Parkinson 5.91 ± 0.33 s, Parkinson's + estrogen 3.48 ± 0.42 s and landing time for control 5.30 ± 0.59 s, ovariectomy 5.45 ± 0.73 s, Parkinson 9.80 ± 0.90 s, Parkinson's + estrogen 5.37 ± 1.02 s). Parkinson's group had longest (90.71 ± 12.56 s) swimming time to reach the target when compared with control (33.16 ± 8.68 s), ovariectomy (47.37 ± 12.19 s), and Parkinson's + estrogen (49.82 ± 5.78 s). Histopathological examination indicated a significant difference in tyrosine hydroxylase-stained cells (dopaminergic neurons and dopamine) between the Parkinson's + estrogen group and the Parkinson's group. The biochemical analyses of Caspas-3 activation in SN and striatum (STR) was significantly different between the Parkinson's + estrogen group and the Parkinson's group, but this difference was not observed in STR while evaluating Bcl-2. The results of this study suggested that estrogen may have a recuperative effect on PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In PD models, oestrogen enhances the neuroprotective function of astrocytes, reduces the vulnerability of substantia nigra dopaminergic neurons,470 and improves motor deficits.471”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [471]
Citations
Cites
1 retracted
An overview of randomization techniques: An unbiased assessment of outcome in clinical research
Suresh, K. (2011) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.82352 · Cited by 1,070
RetractedGreen, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180 · cited 1×
“For this purpose, a flotation pool (diameter 150 cm, depth 60 cm) was prepared as described by Morris (1984).”
MethodDeath Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866 · cited 2×
“…both physiologically and pathologically (Brill et al. 1999), and has a crucial role in development of PD. Apoptosis is induced in two main pathways: activation of cell surface death receptors (extrinsic pathway) (Ashkenazi and Dixit 1998) or mitochondria (intrinsic pathway) (Green and Reed 1998).”
BackgroundDauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · cited 1×
“Rotenone blocks the complex-I unit of the electron transport chain through accumulation in mitochondria (Dauer and Przedborski 2003; Blandini and Armentero 2012).”
BackgroundCaspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719 · cited 1×
“In the mammalian system, caspases may be grouped as inflammatory caspases (caspases 1, 4, 5), effector or executive caspases (caspases 3, 6, 7), and initiator caspases (caspases 2, 8, 9, 10) (Cohen 1997).”
BackgroundEpidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641 · cited 2×
“…protein family contains pro-apoptotic and anti-apoptotic proteins that fulfill an important function in regulation of apoptosis, particularly in the upstream of irreversible cellular damage, and play a major role in the intrinsic pathway that proceeds on the mitochondrial level (Gross et al. 1999).”
BackgroundCaspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256 · cited 1×
“The role of initiator caspases and effector caspases is very important for cell death by both intrinsic and extrinsic apoptosis (Nakagawa et al. 2000).”
BackgroundPathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283 · cited 2×
“2004) and uncontrolled motor behavioral disorders, postural imbalance, stiffness (Lotharius and Brundin 2002), and bradykinesia (Recchia et al.”
Background
Research works printed but not linked: 1
- Borse LB, Muthu AK, Thangatripathi A, Borse SL (2011) CNS activity of the methanol extracts of heartwood of Tecoma stans in experimental animal model. Pharmacologyonline 3:745–754
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“471 Anti-in fl ammation .”
Parkinson's disease and glucose metabolism impairment
Chen, L., Wang, C., Qin, L., & Zhang, H. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00467-8 · Cited by 57
Sex and Brain: The Role of Sex Chromosomes and Hormones in Brain Development and Parkinson’s Disease
Terrin, F., Tesoriere, A., Plotegher, N., & Valle, L. D. (2023) · Cells · doi:10.3390/cells12111486 · Cited by 35
“Similar results have recently been obtained using a rotenone animal model of PD [152].”
He, W., Zhang, S., Qi, Z., & Liu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107201 · Cited by 33
Unda, S. R., Marciano, S., Milner, T. A., & Marongiu, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.971007 · Cited by 19
“…substantia nigra and striatum of females as compared to males with PD. Conversely, treatment with estrogen reduces dopaminergic neurodegeneration in the substantia nigra and restores dopaminergic transmission (Disshon and Dluzen, 2000; Mitra et al., 2015; Shen et al., 2017; Makav and Eroglu, 2021).”
Background
Metadata
- Authors
- Makav, M., & Eroğlu, H. A.
- Affiliations
- Kafkas University (TR)
- Çanakkale Onsekiz Mart Üniversitesi (TR)
- Corresponding author
- Makav, Mustafa
- Venue
- Environmental Science and Pollution Research
- Published
- 2021-01-07
- Volume
- 28
- Issue
- 17
- Pages
- 21266-21275
- ISSN
- 0944-1344 (ISSN-L)
- 1614-7499
- OpenAlex
- W3119319657
- Cited by
- 16
- References
- 65
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 3 · 2022: 2
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Environmental Science and Pollution Research (publishedVersion)
- PubMed (publishedVersion)
- Çanakkale Onsekiz Mart University AVESIS (submittedVersion)
- Çanakkale Onsekiz Mart University Institutional Repository (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- Parkinson's disease, estrogen, estradiol, rotenone, neuroprotection, ovariectomy, menopause, dopaminergic neurons, substantia nigra, motor function, rotarod test, pole test, swimming test, neurotoxicity, female rats, sex differences in neurodegeneration, estrogen replacement therapy, neuroinflammation, oxidative stress
- MeSH terms
- Animals, Disease Models, Animal, Estrogens, Female, Humans, Parkinson Disease, Rotenone, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recuperative effect of estrogen on rotenone-induced experimental model of Parkinson’s disease in rats. https://app.cochat.ai/papers/10.1007/s11356-020-11985-5
- The paper
- Makav, M., & Eroğlu, H. A. (2021). Recuperative effect of estrogen on rotenone-induced experimental model of Parkinson’s disease in rats. Environmental Science and Pollution Research. https://doi.org/10.1007/s11356-020-11985-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.